Study summary

Low-dose semaglutide reduced craving and drinks on drinking days

Low-dose semaglutide trial (UNC) · 48 people, phase 2 · Published April 2025, JAMA Psychiatry

What was tested

Weekly low-dose semaglutide or placebo for 9 weeks in adults with alcohol use disorder who were not seeking treatment.

What they found

What it means

Early evidence that justified the larger trials now running.

JAMA Psychiatry, via PubMed ↗ Trial record NCT05520775 ↗ ← Back to the outlook
Last reviewed 2026-11-16 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.